26 April 2019 - Deborah Wilkes
Premium
Bayer Consumer Health struggled in the first quarter of 2019, reporting worldwide sales down by 1.4% on a currency- and portfolio-adjusted basis to EUR1.40 billion (USD1.57 billion). Bayer's chief executive officer Werner Baumann said the business was expected to strengthen "gradually" in the coming quarters.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.